Oramed Pharmaceuticals, Inc. (ORMP)
5.21
+0.39
(+8.09%)
USD |
NASDAQ |
Aug 25, 16:00
5.29
+0.08
(+1.54%)
Pre-Market: 09:21
Oramed Pharmaceuticals Price : 5.21 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 4.80 | 5.25 | 4.80 | 5.21 | 641502.0 |
| Aug 24, 2026 | 4.80 | 4.86 | 4.74 | 4.82 | 90739.00 |
| Aug 21, 2026 | 4.81 | 4.88 | 4.75 | 4.81 | 126130.0 |
| Aug 20, 2026 | 4.78 | 4.860 | 4.68 | 4.79 | 177177.0 |
| Aug 19, 2026 | 4.83 | 4.94 | 4.70 | 4.79 | 363167.0 |
| Aug 18, 2026 | 4.56 | 4.82 | 4.48 | 4.78 | 300901.0 |
| Aug 17, 2026 | 4.53 | 4.60 | 4.44 | 4.57 | 223942.0 |
| Aug 14, 2026 | 4.30 | 4.53 | 4.30 | 4.48 | 156769.0 |
| Aug 13, 2026 | 4.35 | 4.45 | 4.30 | 4.38 | 152016.0 |
| Aug 12, 2026 | 4.27 | 4.47 | 4.22 | 4.27 | 162886.0 |
| Aug 11, 2026 | 4.21 | 4.349 | 4.16 | 4.25 | 164148.0 |
| Aug 10, 2026 | 4.31 | 4.35 | 4.18 | 4.20 | 167508.0 |
| Aug 07, 2026 | 4.30 | 4.38 | 4.28 | 4.30 | 110557.0 |
| Aug 06, 2026 | 4.27 | 4.415 | 4.25 | 4.30 | 187552.0 |
| Aug 05, 2026 | 4.48 | 4.52 | 4.31 | 4.32 | 162436.0 |
| Aug 04, 2026 | 4.38 | 4.475 | 4.22 | 4.46 | 242754.0 |
| Aug 03, 2026 | 4.11 | 4.40 | 4.06 | 4.39 | 282519.0 |
| Jul 31, 2026 | 4.12 | 4.125 | 3.942 | 4.07 | 208669.0 |
| Jul 30, 2026 | 4.00 | 4.14 | 3.98 | 4.12 | 150186.0 |
| Jul 29, 2026 | 4.18 | 4.19 | 3.96 | 3.97 | 130693.0 |
| Jul 28, 2026 | 4.16 | 4.18 | 4.06 | 4.17 | 112704.0 |
| Jul 27, 2026 | 4.06 | 4.165 | 4.06 | 4.16 | 73126.00 |
| Jul 24, 2026 | 4.18 | 4.18 | 3.96 | 4.03 | 134463.0 |
| Jul 23, 2026 | 3.98 | 4.185 | 3.95 | 4.16 | 152257.0 |
| Jul 22, 2026 | 4.01 | 4.085 | 4.00 | 4.02 | 161588.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1233.66 |
| Pfizer Inc. | 28.57 |
| Yarrow Bioscience, Inc. | 39.25 |
| Liquidia Corp. | 70.49 |
| NRX Pharmaceuticals, Inc. | 3.67 |
Price Related Metrics
| PE Ratio | 1.268 |
| Price to Book Value | 0.678 |
| Earnings Yield | 78.90% |
| Market Cap | 215.25M |
| Normalized PE Ratio | 4.97 |